» Articles » PMID: 30464239

Anti-obesity Activity of OBEX is Regulated by Activation of Thermogenesis and Decreasing Adiposity Gain

Overview
Journal Sci Rep
Specialty Science
Date 2018 Nov 23
PMID 30464239
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of obesity has been increasing dramatically worldwide over the past decades, thus requiring novel and effective therapeutic approaches. OBEX is an oral nutritional supplement composed of antioxidants with antiobesity activity. The effects of OBEX have been tested in vivo and in vitro. In vivo, OBEX reduces weight gain by decreasing adiposity gain and increasing energy expenditure in high fat diet-fed mice through the activation of thermogenesis in brown adipose tissue (BAT) independent of eating behaviors. In vitro analysis with 3T3-F442A cells revealed anti-proliferative and anti-differentiation effects of OBEX. In addition, OBEX induced a clear reduction of the lipid load in mature adipocytes obtained from 3T3-F442A cells. Overall, our findings suggest that OBEX has a protective effect against an obesogenic environment.

Citing Articles

Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial.

Cabrera-Rode E, Cubas-Duenas I, Acosta J, Hernandez J, Gonzalez A, Calero T BMC Complement Med Ther. 2023; 23(1):58.

PMID: 36804035 PMC: 9940432. DOI: 10.1186/s12906-023-03847-7.


Oxytocin Involvement in Body Composition Unveils the True Identity of Oxytocin.

Camerino C Int J Mol Sci. 2021; 22(12).

PMID: 34203705 PMC: 8232088. DOI: 10.3390/ijms22126383.

References
1.
Power R, Hulver M, Zhang J, Dubois J, Marchand R, Ilkayeva O . Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia. 2007; 50(4):824-32. PMC: 5682624. DOI: 10.1007/s00125-007-0605-4. View

2.
Muir L, Neeley C, Meyer K, Baker N, Brosius A, Washabaugh A . Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity. Obesity (Silver Spring). 2016; 24(3):597-605. PMC: 4920141. DOI: 10.1002/oby.21377. View

3.
Imbernon M, Beiroa D, Vazquez M, Morgan D, Veyrat-Durebex C, Porteiro B . Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology. 2012; 144(3):636-649.e6. PMC: 3663042. DOI: 10.1053/j.gastro.2012.10.051. View

4.
Anastasovska J, Arora T, Sanchez Canon G, Parkinson J, Touhy K, Gibson G . Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment. Obesity (Silver Spring). 2012; 20(5):1016-23. DOI: 10.1038/oby.2012.6. View

5.
Bray G . Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab. 2008; 93(11 Suppl 1):S81-8. PMC: 2585762. DOI: 10.1210/jc.2008-1294. View